MELTEMI BIOTHERAPEUTICS

Serial Number 85449726
606

Registration Progress

Application Filed
Oct 18, 2011
Under Examination
May 29, 2012
Approved for Publication
Mar 14, 2012
Published for Opposition
Apr 3, 2012
Registered

Basic Information

Serial Number
85449726
Filing Date
October 18, 2011
Published for Opposition
April 3, 2012
Abandonment Date
June 29, 2015
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 29, 2015
Classes
005 042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 3rd Street, 3rd Floor
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description
Jun 29, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 29, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 7, 2015 DOCK D ASSIGNED TO EXAMINER
Oct 22, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Oct 21, 2014 EX5G S SOU EXTENSION 5 GRANTED
Oct 17, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 17, 2014 EXT5 S SOU EXTENSION 5 FILED
Apr 2, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Apr 1, 2014 EX4G S SOU EXTENSION 4 GRANTED
Mar 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 13, 2014 EXT4 S SOU EXTENSION 4 FILED
Sep 24, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 23, 2013 EX3G S SOU EXTENSION 3 GRANTED
Sep 10, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 10, 2013 EXT3 S SOU EXTENSION 3 FILED
May 17, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
May 16, 2013 EX2G S SOU EXTENSION 2 GRANTED
May 10, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 18, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 18, 2013 EXT2 S SOU EXTENSION 2 FILED
Dec 1, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Nov 29, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 29, 2012 EXT1 S SOU EXTENSION 1 FILED
Nov 29, 2012 EX1G S SOU EXTENSION 1 GRANTED
May 29, 2012 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 3, 2012 PUBO A PUBLISHED FOR OPPOSITION
Mar 14, 2012 NPUB O NOTICE OF PUBLICATION
Mar 1, 2012 ALIE A ASSIGNED TO LIE
Mar 1, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2012 CNEA F EXAMINER'S AMENDMENT MAILED
Feb 13, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 13, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2012 DOCK D ASSIGNED TO EXAMINER
Oct 22, 2011 MDSM O NOTICE OF DESIGN SEARCH CODE MAILED
Oct 21, 2011 NWAP I NEW APPLICATION ENTERED
Oct 21, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
scientific research, scientific research in the fields of pharmaceuticals, biosimilars, biologics, and medicine
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the word "MELTEMI" positioned over the word "BIOTHERAPEUTICS" with a stylized design to the upper right of the two words.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
MELT EMI BIO THERAPEUTICS

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTHERAPEUTICS"